UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Platelet‐derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP‐2 production

International journal of cancer, 2009-04, Vol.124 (8), p.1773-1777

2009

Volltextzugriff (PDF)

Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition

PloS one, 2016-12, Vol.11 (12), p.e0166655-e0166655

2016

Volltextzugriff (PDF)

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006238

2023

Volltextzugriff (PDF)

Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia

Current neurovascular research, 2012-08, Vol.9 (3), p.185-192

2012

Volltextzugriff (PDF)

C‐reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis

British journal of haematology, 2006-08, Vol.134 (4), p.426-431

2006

Volltextzugriff (PDF)

Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization

Cardiovascular research, 2005-07, Vol.67 (1), p.30-38

2005

Volltextzugriff (PDF)

Functional Characterization of Genes Residing in Chromosomal Regions with “High-Risk” Lesions in Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.3293-3293

2023

Volltextzugriff (PDF)

Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration

Thrombosis research, 2012-10, Vol.130, p.S98-S99

2012

Volltextzugriff (PDF)

Systematic Functional Characterization for Loss of Function Events Cooperating with TP53 Loss in High-Risk 17p13(del) Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.7110-7111

2022

Volltextzugriff (PDF)

Targeting Mutant KRAS with Novel Mutant-Specific Pharmacological Inhibitors: Activity Against Myeloma and Other Lymphoid Malignant Cells and Molecular Mechanisms of Resistance

Blood, 2023-11, Vol.142 (Supplement 1), p.4186-4186

2023

Volltextzugriff (PDF)

Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.732-732

2021

Volltextzugriff (PDF)

Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke

Thrombosis and haemostasis, 2013-08, Vol.110 (2), p.323-330

2013

Volltextzugriff (PDF)

P-248 CRISPR-Based Functional Genomics Studies Identify Mechanisms of Multiple Myeloma (MM) Cell Response to vs. Resistance Against Novel Pharmacological Mutant-Specific KRAS Inhibitors

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S180-S181

2024

Volltextzugriff (PDF)

Natural Killer Cells Are Active Against Myeloma, Leukemia or Lymphoma Cells with Loss of Tumor Suppressor Genes

Blood, 2023-11, Vol.142 (Supplement 1), p.6842-6842

2023

Volltextzugriff (PDF)

NF-κB dysregulation in multiple myeloma

Seminars in cancer biology, 2016-08, Vol.39, p.68-76

2016

Volltextzugriff (PDF)

Functional Oncogenomic and Immune Response Landscape for Genes Recurrently Mutated in Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.1589-1589

2021

Volltextzugriff (PDF)

Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.1612-1612

2021

Volltextzugriff (PDF)

P-373 Functional genomics of genes residing in the minimally deleted chromosome 17p13 region in multiple myeloma: therapeutic implications

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S245-S246

2023

Volltextzugriff (PDF)

Identification of Molecular Markers of Tumor Cell Sensitivity and Resistance to Natural Killer Cells through Genome-Wide CRISPR Activation and CRISPR Editing Screens in Multiple Myeloma Cell Lines: Implications for Anti-Myeloma Immunotherapy

Blood, 2018-11, Vol.132 (Supplement 1), p.1115-1115

2018

Volltextzugriff (PDF)

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

The Journal of clinical investigation, 2023-11, Vol.133 (22), p.1-20

2023

Volltextzugriff (PDF)

Functional Characterization of Genes Driving Enhanced Biological Aggressiveness of Myeloma Cells: Identification of Novel and Understudied “Drivers” of Myeloma

Blood, 2019-11, Vol.134 (Supplement_1), p.313-313

2019

Volltextzugriff (PDF)

Functional Interactions between Transcription Factors Involved in Myeloma Pathogenesis - Biological and Therapeutic Implications

Blood, 2019-11, Vol.134 (Supplement_1), p.315-315

2019

Volltextzugriff (PDF)

Heterogeneity of Molecular Mechanisms Determining Blood Cancer Cell Lines Resistance to Natural Killer Cells in the Context of Tumor-Stromal Interactions: Insights from Studies of Pooled “DNA-Barcoded” Cell Line Panels

Blood, 2019-11, Vol.134 (Supplement_1), p.620-620

2019

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(63)
Tagungsberichte
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Platelet‐derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP‐2 production

Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells

Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia

C‐reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis

Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization

Functional Characterization of Genes Residing in Chromosomal Regions with “High-Risk” Lesions in Multiple Myeloma

Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration

Systematic Functional Characterization for Loss of Function Events Cooperating with TP53 Loss in High-Risk 17p13(del) Multiple Myeloma

Genome-scale screens identify factors regulating tumor cell responses to natural killer cells

Targeting Mutant KRAS with Novel Mutant-Specific Pharmacological Inhibitors: Activity Against Myeloma and Other Lymphoid Malignant Cells and Molecular Mechanisms of Resistance

Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma

Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke

P-248 CRISPR-Based Functional Genomics Studies Identify Mechanisms of Multiple Myeloma (MM) Cell Response to vs. Resistance Against Novel Pharmacological Mutant-Specific KRAS Inhibitors

Natural Killer Cells Are Active Against Myeloma, Leukemia or Lymphoma Cells with Loss of Tumor Suppressor Genes

NF-κB dysregulation in multiple myeloma

Functional Oncogenomic and Immune Response Landscape for Genes Recurrently Mutated in Myeloma

Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma

Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers

P-373 Functional genomics of genes residing in the minimally deleted chromosome 17p13 region in multiple myeloma: therapeutic implications

Identification of Molecular Markers of Tumor Cell Sensitivity and Resistance to Natural Killer Cells through Genome-Wide CRISPR Activation and CRISPR Editing Screens in Multiple Myeloma Cell Lines: Implications for Anti-Myeloma Immunotherapy

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Functional Characterization of Genes Driving Enhanced Biological Aggressiveness of Myeloma Cells: Identification of Novel and Understudied “Drivers” of Myeloma

Functional Interactions between Transcription Factors Involved in Myeloma Pathogenesis - Biological and Therapeutic Implications

Heterogeneity of Molecular Mechanisms Determining Blood Cancer Cell Lines Resistance to Natural Killer Cells in the Context of Tumor-Stromal Interactions: Insights from Studies of Pooled “DNA-Barcoded” Cell Line Panels

Suchergebnisse filtern